Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-07

Clinical Trial Update: Study of Salmeterol (SN408D) for Adult Asthma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completion update for Salmeterol (SN408D) in adult asthma, sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Serevent (salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma, Bronchial Asthma | Phase 4 | Status: COMPLETED